GL1X · GenesisL1 explorer

MolNFT v1 · #67511 · protein

Crystal structure of the GRB2 SH2 domain in complex with a cyclopropyl-constrained ac-ptyr-ile-asn-NH2 tripeptide mimic

3IMJ · Growth factor receptor-bound protein 2: “Crystal structure of the GRB2 SH2 domain in complex with a cyclopropyl-constrained ac-ptyr-ile-asn-NH2…”. X-ray diffraction, 1 ligand (AYI), 1 pocket (best druggability 0.39). MolNFT v1…

PDB
3IMJ
Type
protein
Length
201 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Growth factor receptor-bound protein 2
UniProt
P62993
Ligands
AYI
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGrowth factor receptor-bound protein 2protein10116% helix, 27% strandP62993
BGrowth factor receptor-bound protein 2protein10016% helix, 27% strandP62993

Ligands and binding sites

  • AYI · (1R,2S,3R,1S',1S")Phosphoric acid mono(4-{2-[1-(1,2-dicarbamoylethylcarbamoyl)-3-carbamoylpropylcarbamoyl]-3-methylcarbamoylcyclopropyl}phenyl) ester · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11210.390.7417empty

Interfaces

1 interface between chains.

  • A–B · 1090 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 3IMJ · Crystal Structure of the Grb2 SH2 Domain in Complex with a Cyclopropyl-constrained… · the same entry in another collection · chain B against B, TM-score 1.00
  • P62993 · AlphaFold monomer V2.0 prediction for growth factor receptor-bound protein 2 (P62993) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.